Records containing: Migraine
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-07-03An Open-Label, 12-Month Study to Evaluate the Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
-
CLINICAL_TRIALS study record update · 2023-06-29STOP PAIN: Septal Closure of PFO - Does it Prevent Migraine?
-
CLINICAL_TRIALS study record update · 2023-06-29EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
-
CLINICAL_TRIALS study record update · 2023-06-26Prevalence of Migraine Disease in Electrohypersensitive Patients
-
CLINICAL_TRIALS study record update · 2023-06-22Discovering the Functional Role of the Glymphatic System in the Genesis of the Migraine Attack
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-06-15Treatment of Insomnia in Migraineurs With Eszopiclone (Lunesta™) and Its Effect on Sleep Time, Headache Frequency, and Daytime Functioning: a Randomized, Double-blind, Placebo-controlled, Parallel-group Pilot Study
-
CLINICAL_TRIALS study record update · 2023-06-08Expression of miR-155 in Migraine: Association With Different Phenotypes and Disease Severity
-
CLINICAL_TRIALS study record update · 2023-05-31A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine When Administered During the Prodrome
-
CLINICAL_TRIALS study record update · 2023-05-10Automated Variable Pattern Insufflator Device (AVPI) for the Acute Treatment of Migraine: a Multicenter, Double-blind, Randomized, Sham-controlled Trial
-
CLINICAL_TRIALS study record update · 2023-05-10LSFG-SKIN, Laser Speckle Flowgraphy
-
CLINICAL_TRIALS study record update · 2023-04-21The Impact of Migraine on Canadians' Productivity: A Real-World Pharmacy-Based Study
-
CLINICAL_TRIALS study record update · 2023-04-12Investigation of the Effects of a Client-centered Coping Skills Training in Individuals With Migraine: A Randomized Controlled Study
-
CLINICAL_TRIALS study record update · 2023-03-28Influence of Ubrogepant and Sumatriptan on the Dermal Blood Flow Response After a Histamine Skin Prick as Well as After the Topical Application of Cinnamaldehyde and Capsaicin
-
CLINICAL_TRIALS study record update · 2023-03-22Characteristics of Health Insurance Beneficiaries With a Triptan Prescription in the Grand Est Region, France, in 2018-2019 - PASENREGE Study
-
CLINICAL_TRIALS study record update · 2023-03-16Double-Blind, Randomized, Placebo-controlled, Safety and Efficacy Trial of BHV-3500 (Zavegepant) Intranasal for the Acute Treatment of Migraine
-
CLINICAL_TRIALS study record update · 2023-03-15A Prospective, Randomized, Double-blind, Sham-controlled Multi-center Clinical Study Assessing the Safety and Efficacy of Nerivio for the Preventive Treatment of Migraine
-
CLINICAL_TRIALS study record update · 2023-03-14Calcitonin Gene-Related Peptide (CGRP) and Neurophysiological Biomarkers of Migraine
-
CLINICAL_TRIALS study record update · 2023-03-08Topiramate, Amitriptyline Monotherapy and Combination Therapy in Migraine Prophylaxis: An Open Label Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2023-03-03Integrative Migraine Pain Alleviation Through Chiropractic Therapy
-
CLINICAL_TRIALS study record update · 2023-03-02Effects of Myofascial Trigger Points Therapy in Migraine.
-
CLINICAL_TRIALS study record update · 2023-03-01Phase I, Open-Label, Randomized, Single Sequence Study With Two Dose Groups to Compare the Pharmacokinetics of BMS-927711 in Migraine Subjects During an Acute Migraine Attack and During Non-Migraine Period
-
CLINICAL_TRIALS study record update · 2023-02-28Efficacy of Inhaled Cannabis Versus Placebo for the Acute Treatment of Migraine: a Randomized, Double-blind, Placebo-controlled, Crossover Trial
-
CLINICAL_TRIALS study record update · 2023-02-23BHV3000-401: An Open-label, Intermediate-size, Expanded Access Study of BHV-3000 in the Acute Treatment of Migraine
-
CLINICAL_TRIALS study record update · 2023-02-08Habituation of the Nociceptive Blink Reflex in Experimentally Induced Migraine Attack: a Cross-over, Randomized Controlled Study
-
CLINICAL_TRIALS study record update · 2023-01-19Digital-technology Based Interventions on Treatment of Migraine.